HUP9903804A1 - Nagy hatóanyag-szabadonbocsátású gombaölő hatású gél - Google Patents

Nagy hatóanyag-szabadonbocsátású gombaölő hatású gél

Info

Publication number
HUP9903804A1
HUP9903804A1 HU9903804A HUP9903804A HUP9903804A1 HU P9903804 A1 HUP9903804 A1 HU P9903804A1 HU 9903804 A HU9903804 A HU 9903804A HU P9903804 A HUP9903804 A HU P9903804A HU P9903804 A1 HUP9903804 A1 HU P9903804A1
Authority
HU
Hungary
Prior art keywords
active substance
high active
substance release
antimycotic
gel
Prior art date
Application number
HU9903804A
Other languages
English (en)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Astrid Markus
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7807116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP9903804(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of HUP9903804A1 publication Critical patent/HUP9903804A1/hu
Publication of HUP9903804A3 publication Critical patent/HUP9903804A3/hu
Publication of HU228297B1 publication Critical patent/HU228297B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

A találmány tárgyát hidrőfil gélképző szert, vizet és (I) általánősképletű vegyületet tartalmazó készítmények bőrgőmbásődás kezelésére ésmegelőzésére történő alkalmazása képezi. A képletben R1, R2 és R3 jelentése azőnős vagy különböző, és jelentésükhidrőgénatőm vagy 1-4 szénatőmős alkilcsőpőrt, és R4 jelentése telített 6-9 szénatőmős szénhidrőgéncsőpőrt. ŕ
HU9903804A 1996-09-27 1997-09-16 Antimycotic gel with high active substance release HU228297B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19639816A DE19639816A1 (de) 1996-09-27 1996-09-27 Antimykotische Mittel mit hoher Wirkstofffreisetzung
PCT/EP1997/005068 WO1998013042A1 (de) 1996-09-27 1997-09-16 Antimykotisches gel mit hoher wirkstofffreisetzung

Publications (3)

Publication Number Publication Date
HUP9903804A1 true HUP9903804A1 (hu) 2000-03-28
HUP9903804A3 HUP9903804A3 (en) 2003-05-28
HU228297B1 HU228297B1 (en) 2013-03-28

Family

ID=7807116

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903804A HU228297B1 (en) 1996-09-27 1997-09-16 Antimycotic gel with high active substance release

Country Status (35)

Country Link
US (3) US7018656B2 (hu)
EP (1) EP0928192B1 (hu)
JP (1) JP2001501609A (hu)
KR (1) KR100457850B1 (hu)
CN (1) CN1149992C (hu)
AR (1) AR008858A1 (hu)
AT (1) ATE216882T1 (hu)
AU (1) AU718837B2 (hu)
BG (1) BG63864B1 (hu)
BR (1) BR9711559A (hu)
CA (1) CA2267160C (hu)
CY (1) CY2371B1 (hu)
CZ (1) CZ291170B6 (hu)
DE (2) DE19639816A1 (hu)
DK (1) DK0928192T3 (hu)
ES (1) ES2176702T3 (hu)
HK (1) HK1022268A1 (hu)
HU (1) HU228297B1 (hu)
ID (1) ID22149A (hu)
IL (1) IL129140A (hu)
MA (1) MA24331A1 (hu)
MY (1) MY117863A (hu)
NO (1) NO321899B1 (hu)
NZ (1) NZ334849A (hu)
OA (1) OA11026A (hu)
PL (1) PL188840B1 (hu)
PT (1) PT928192E (hu)
RS (1) RS49596B (hu)
RU (1) RU2181281C2 (hu)
SI (1) SI0928192T1 (hu)
TR (1) TR199900723T2 (hu)
TW (1) TW558442B (hu)
UA (1) UA52699C2 (hu)
WO (1) WO1998013042A1 (hu)
ZA (1) ZA978638B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
WO2003105903A1 (ja) * 2002-06-18 2003-12-24 ポーラ化成工業株式会社 抗真菌医薬組成物
CN100425233C (zh) * 2005-01-12 2008-10-15 复旦大学 一种鼻腔用尼莫地平凝胶剂
US20080176908A1 (en) * 2007-01-18 2008-07-24 Mcanally Weylan R Method of using squalene monooxygenase inhibitors to treat acne
MX2007009796A (es) * 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
WO2010069519A1 (en) 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Topical compositions comprising at least one active ingredient poorly soluble in water and biopolymers such as hyaluronic acid with a pka-value between 5-7
US8618175B2 (en) * 2010-07-19 2013-12-31 Brussels Ventures Corp. Ultrasound medical gel composition etherified hydroxyethylcellulose
CN105797696A (zh) * 2016-03-23 2016-07-27 广东省工程技术研究所 一种分子印迹整体柱的制备方法
WO2019198896A1 (ko) * 2018-04-12 2019-10-17 숙명여자대학교산학협력단 식품 신선도 유지를 위한 항균성 하이드로겔

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968118A (en) 1968-08-31 1976-07-06 Hoechst Aktiengesellschaft Process for the manufacture of 1-hydroxy-2-pyridones
NL156397B (nl) * 1968-08-31 1978-04-17 Hoechst Ag Werkwijze voor het bereiden van preparaten tegen schimmelaandoeningen, gevormde preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen.
US4185106A (en) 1972-07-11 1980-01-22 Hoechst Aktiengesellschaft Pyridones as antidandruff agents
DE3140954A1 (de) * 1981-10-15 1983-05-05 Hoechst Ag "verwendung von 1-hydroxy-2-pyridonen zur prophylaxe und behandlung von akne"
GB8302683D0 (en) 1983-02-01 1983-03-02 Unilever Plc Skin treatment composition
JPS6169721A (ja) 1984-09-13 1986-04-10 Kao Corp 抗真菌組成物
GB8524508D0 (en) * 1985-10-04 1985-11-06 Beecham Group Plc Composition
DE3687458T2 (de) 1985-11-04 1993-07-29 Owen Galderma Lab Inc Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
AR242187A1 (es) 1986-04-18 1993-03-31 Hoechst Ag Procedimiento para la preparacion de 1-hidroxi-2-piridonas, obtencion de medicamentos que las contienen, e intermediarios utiles en dicho procedimiento.
NL8601762A (nl) 1986-07-07 1988-02-01 Bouke Jan Lange Werkwijze voor de reiniging en conditionering en eventuele medicinale behandeling van het haar en de hoofdhuid, een voor dit doel bruikbare tweefasen shampoo, alsmede een verpakking daarvoor.
JPS63230640A (ja) * 1987-03-19 1988-09-27 Shiseido Co Ltd 経皮吸収促進剤及びこれを含有する皮膚外用製剤
US5641475A (en) 1987-05-15 1997-06-24 Tristrata, Inc. Antiodor, antimicrobial and preservative compositions and methods of using same
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
LU86945A1 (fr) * 1987-07-17 1989-03-08 Oreal Compositions pharmaceutiques et cosmetiques a base de pyridones et d'agents antibacteriens
LU86944A1 (fr) 1987-07-17 1989-03-08 Oreal Composition a base de derives d'hydroxypyridone pour diminuer la chute des cheveux
JPS6468327A (en) * 1987-09-08 1989-03-14 Teisan Seiyaku Kk Warming type insulin-containing plaster
ATE176396T1 (de) 1987-10-22 1999-02-15 Procter & Gamble Chelatbildner enthaltende lichtschutzmittel
WO1993012762A1 (en) * 1988-03-22 1993-07-08 Yoshikazu Soyama Manicuring preparation
HU202098B (en) 1988-08-05 1991-02-28 Istvan Laczko Nail polish remover without aceton
DE3826914A1 (de) * 1988-08-09 1990-02-15 Henkel Kgaa Farbstabilisierung von antimikrobiellen zubereitungen
US5116603A (en) 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
JPH03120230A (ja) * 1989-10-04 1991-05-22 Nippon Mining Co Ltd 薬効成分の経皮吸収促進剤及び経皮吸収型製剤
JPH0623087B2 (ja) 1989-10-09 1994-03-30 花王株式会社 洗浄剤組成物
FR2653123B1 (fr) 1989-10-17 1992-01-17 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5066484A (en) 1990-04-30 1991-11-19 Revlon, Inc. Nail enamels containing glyceryl, glycol or citrate esters
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
FR2685638A1 (fr) 1991-12-31 1993-07-02 Biorga Sa Laboratoires Compositions pour l'usage cosmetique et/ou dermatologique, comprenant une association de pyrithione zinc, de piroctone olamine, et d'un derive de collagene et d'acide gras.
FR2685867B1 (fr) 1992-01-07 1995-06-09 Thorel Jean Compositions contre la desquamation de l'epiderme et du cuir chevelu.
DE4212105A1 (de) 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
FR2694694B1 (fr) 1992-08-13 1994-10-28 Thorel Jean Noel Composition active pour le traitement du psoriasis, notamment le psoriasis du cuir chevelu.
KR950702819A (ko) 1992-09-08 1995-08-23 제이코버스 코넬리스 레이서 실질적으로 무색의 순한 샴푸 조성물(mild, substantially coloriess shampoo compostion)
FR2697749B1 (fr) 1992-11-12 1995-01-13 Oreal Composition cosmétique filmogène à base d'un copolymère chloré greffé résultant du greffage d'une polyoléfine chlorée et de monomères insaturés du type acrylique, styrénique et/ou vinylique.
DE4333893A1 (de) 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
DE19518262A1 (de) 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
JP2945244B2 (ja) * 1993-05-24 1999-09-06 帝三製薬株式会社 酢酸ビニール系粘着剤を用いた硝酸イソソルビド含有貼付剤
FR2706299B1 (fr) * 1993-06-10 1995-09-01 Oreal Emulsion cosmétique ou dermatologique huile-dans-eau contenant une composition auto-émulsionnable à base d'un alcool gras et d'un alkylpolyoside et un co-émulsionnant.
ES2148340T3 (es) * 1993-09-01 2000-10-16 Teijin Ltd Composicion de emulsion de 1-alfa,24-(oh)2-vitamina d3.
US5424435A (en) 1993-10-18 1995-06-13 Olin Corporation 1-hydroxy-6-substituted-2-pyridones
DE4336434A1 (de) 1993-10-26 1995-04-27 Hoechst Ag Pharmazeutische Zubereitung für die parenterale, enterale und dermale Verabreichung von praktisch unlöslichen Arzneistoffen und Verfahren zu ihrer Herstellung
US5480904A (en) 1993-10-28 1996-01-02 Eli Lilly And Company Methods for inhibiting uterine fibrosis
WO1995017165A2 (en) 1993-12-23 1995-06-29 The Procter & Gamble Company Tissue moisturizing and antimicrobial compositions
JP3629283B2 (ja) * 1994-02-15 2005-03-16 ポーラ化成工業株式会社 皮膚外用剤
FR2718349B1 (fr) 1994-04-07 1996-05-31 Oreal Compositions cosmétiques à appliquer sur l'ongle.
JPH07325488A (ja) 1994-04-08 1995-12-12 Nippon Steel Corp 画像形成方法及び画像形成装置
FR2719481B1 (fr) 1994-05-05 1996-05-31 Oreal Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.
FR2722689B1 (fr) 1994-07-20 1996-10-04 Fabre Pierre Dermo Cosmetique Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant
JPH08165244A (ja) * 1994-10-12 1996-06-25 Taisho Pharmaceut Co Ltd 皮膚疾患治療剤
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
IL113057A (en) 1995-03-21 1999-01-26 Univ Ramot Compositions for the treatment of dandruff
US5609854A (en) * 1995-06-06 1997-03-11 Elizabeth Arden Company, Division Of Conopco, Inc. Thickened and stabilized cosmetic emulsion compositions
DK0865278T3 (da) 1995-12-04 2002-09-09 Aventis Pharma Gmbh Anvendelse af 1-hydroxy-2-pyridoner til behandling af slimhinde-sygdomme, som er vanskeligt at behandle
DE19643831A1 (de) 1996-10-30 1998-05-07 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von schwer therapierbaren Schleimhauterkrankungen
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
DE19639817A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen
DE19639818A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis
PT983037E (pt) 1998-02-09 2003-09-30 Macrochem Corp Verniz para unhas antifungico
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
DE10011081A1 (de) 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel

Also Published As

Publication number Publication date
RS49596B (sr) 2007-06-04
MA24331A1 (fr) 1998-04-01
US20030190340A1 (en) 2003-10-09
PL188840B1 (pl) 2005-05-31
CA2267160A1 (en) 1998-04-02
DK0928192T3 (da) 2002-08-19
HK1022268A1 (en) 2000-08-04
JP2001501609A (ja) 2001-02-06
US20060121118A1 (en) 2006-06-08
BG63864B1 (bg) 2003-04-30
HUP9903804A3 (en) 2003-05-28
NO991458D0 (no) 1999-03-25
SI0928192T1 (en) 2002-08-31
DE19639816A1 (de) 1998-04-02
IL129140A0 (en) 2000-02-17
BG103262A (en) 1999-09-30
US7018656B2 (en) 2006-03-28
EP0928192A1 (de) 1999-07-14
KR20000048620A (ko) 2000-07-25
TW558442B (en) 2003-10-21
DE59707169D1 (de) 2002-06-06
NO991458L (no) 1999-03-25
RU2181281C2 (ru) 2002-04-20
US20040081677A1 (en) 2004-04-29
HU228297B1 (en) 2013-03-28
AU718837B2 (en) 2000-04-20
NZ334849A (en) 2000-09-29
CZ107399A3 (cs) 1999-07-14
MY117863A (en) 2004-08-30
CY2371B1 (en) 2004-06-04
ATE216882T1 (de) 2002-05-15
ID22149A (id) 1999-09-09
NO321899B1 (no) 2006-07-17
PT928192E (pt) 2002-10-31
CZ291170B6 (cs) 2003-01-15
ES2176702T3 (es) 2002-12-01
BR9711559A (pt) 1999-08-24
WO1998013042A1 (de) 1998-04-02
CA2267160C (en) 2006-10-31
IL129140A (en) 2004-08-31
ZA978638B (en) 1998-03-27
KR100457850B1 (ko) 2004-11-18
CN1231609A (zh) 1999-10-13
YU13599A (sh) 2002-03-18
PL332604A1 (en) 1999-09-27
CN1149992C (zh) 2004-05-19
EP0928192B1 (de) 2002-05-02
AR008858A1 (es) 2000-02-23
TR199900723T2 (xx) 1999-07-21
AU4703797A (en) 1998-04-17
OA11026A (fr) 2003-03-10
US7026337B2 (en) 2006-04-11
UA52699C2 (uk) 2003-01-15

Similar Documents

Publication Publication Date Title
TW200407287A (en) A sulfonated amine acid derivative and the metalloproteinase inhibitor containing it (I)
AU6613896A (en) Chemical compounds
NZ333380A (en) 6-O-methylerythromycin A crystal form I (clarithromycin) and preparation thereof
GB9801690D0 (en) Therapeutic agents
AU3262295A (en) Metalloproteinase inhibitors
DE69325454T2 (de) Taxol-derivate
HUP9903804A1 (hu) Nagy hatóanyag-szabadonbocsátású gombaölő hatású gél
ES2178651T3 (es) Compuestos carotenoides terapeuticos deispersables en agua.
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
AR004688A1 (es) Derivados de la 5-0-desosaminil--6-o-metil-eritronolida a, su procedimiento de preparacion, compuestos intermediarios para su exclusivo uso en dichoprocedimiento para la preparacion de productos biologicamente activo
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
GB9816616D0 (en) Metalloproteinase inhibitors
RS50033B (sr) Derivati etansulfonil-piperidina
ID16479A (id) Senyawa-senyawa pengobatan
AU562643B2 (en) N-arylpiperazine derivatives
AP9901637A0 (en) Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid.
AU567498B2 (en) 5-phenyl-1h-2,3-dihydro-1,4-benzodiazepine derivatives.
ES8402817A1 (es) Procedimiento para la obtencion de nuevas amidas y esteres de acidos hidroxi, amino e hidroxi-amino sulfonicos y de sus sales.
SE9401596D0 (sv) New compounds
FI970452A (fi) Leukotrieenin biosynteesin estäminen ureajohdannaisten avulla
DE69729618D1 (de) Abführmittel und verfahren zu deren herstellung
AU9095291A (en) Sterilising composition
KR900014372A (ko) 티에닐피페라진 이의 제조방법 및 이를 함유하는 약제
UA10395C2 (uk) Спосіб одержаhhя модифікатора гуми